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Abstract
There is growing attention for antimicrobial stewardship in paediatrics. Currently, little is known about secondary care antibiotic
practice. We analysed trends in time with respect to inpatient antibiotic use in a secondary paediatric care setting. Total inpatient
antibiotic consumption per year (2010–2015) and antibiotic prescriptions for urinary tract infection (UTI) and lower respiratory
tract infection (LRTI) were analysed. Variables were total, antibiotic-specific, and intravenous days of therapy (DOT/100PD) and
for UTI/LRTI treatment type, route and duration. Third-generation cephalosporin use decreased (DOT/100PD 11.6 in 2011 vs.
5.1 in 2015; p < 0.001); intravenous antibiotics were prescribed less often (p = 0.06). These findings were confirmed for the
specific diseases: third-generation cephalosporin use decreased for both UTI (93% vs. 45%; p = 0.002) and LRTI (14% vs. 6%;
p = 0.18); the duration of intravenous therapy decreased (UTI p = 0.02; LRTI p < 0.001). Median LRTI treatment duration was
9.2 days in 2008 and 6.6 in 2015 (p < 0.001); penicillin prescriptions were more narrow in spectrum (p = 0.02).
Conclusion: A decrease in third-generation cephalosporin use and intravenous route was identified. LRTI treatment was
significantly shorter and more narrow in spectrum. This could be explained by awareness and interventions in the context of
antimicrobial stewardship. A decrease in antibiotic use is also feasible and important in non-tertiary paediatric wards.
What is Known:
• Antimicrobial stewardship programmes are effective in reduction of total and broad-spectrum antibiotic use in tertiary paediatric hospitals
• The majority of hospitalised paediatric patients are admitted at general, secondary care wards, often for infectious diseases
What is New:
• Antimicrobial stewardship interventions in secondary care are also effective in establishing a reduction in broad-spectrum antibiotic use, intravenous
route and days on antibiotic therapy
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Abbreviations
ASP Antimicrobial stewardship programmes
ATC Anatomical therapeutic chemical
CAP Community-acquired pneumonia
DOT/100 PD Days of therapy per 100 patient-days
DDD Defined daily dose
ENT Ear nose throat
IDSA Infectious Diseases Society of America
LRTI Lower respiratory tract infection
PP Point prevalence
TMP/SMX Trimethoprim/sulfamethoxazole
UTI Urinary tract infection
WHO World Health Organization
Introduction
Given the emergence of antimicrobial resistance and the im-
pact on morbidity and mortality rates, as well as increased
health care costs, appropriate antimicrobial use has become
extremely important [11]. Antimicrobial stewardship refers
to coordinated interventions designed to improve and measure
the appropriate use of antimicrobials by promoting the selec-
tion of the optimal antimicrobial drug regimen, dose, duration
of therapy, and route of administration. Antimicrobial stew-
ards seek to achieve optimal clinical outcomes related to anti-
microbial use, minimise toxicity and other adverse events,
reduce the costs of health care for infections, and limit the
selection for antimicrobial-resistant strains [1]. It also involves
transparent monitoring of prescription data and use of avail-
able expertise and resources [12]. These elements could be
accomplished by education, implementation of clinical prac-
tice guidelines, antimicrobial order forms, and dose optimiza-
tion [4, 5]. Many studies have shown antimicrobial steward-
ship programmes (ASP) to be effective in reducing antibiotic
prescribing, without negatively affecting the quality of care
and patient mortality [19, 25].
ASP are also important in paediatrics. Children and neo-
nates receive antibiotics frequently, because of the nature of
childhood diseases [2, 13, 21]. The type of antibiotic prescrip-
tions varies considerably between paediatric wards, despite
similar clinical outcomes [10, 21]. Evaluations of paediatric
ASP are limited compared to the number of evaluations of
adult programmes [22]. Previous research has shown that
ASP in hospitals are effective in reducing inappropriate anti-
biotic use in hospitalised children [16]. Total and specific
broad-spectrum antibiotic use has decreased significantly in
several paediatric hospitals in the USA since the introduction
of the IDSA guidelines for ASP in 2007 [10, 17]. These de-
clines were greater in hospitals with ASP than in hospitals
without ASP. By routine monitoring, fewer antimicrobial
medication errors were made [6, 10]. Medication prescription
errors in paediatric patients are mainly made with antibiotics
[7]. Moreover, for many infections, intravenous-to-oral
switches could occur earlier [15].
There has been limited development of ASP in paediatrics,
due to the lack of a standardised method of comparing anti-
microbial use between hospitals [21]. Days of therapy (DOT)
and defined daily dose (DDD) are recognised by the WHO to
quantify antimicrobial use [9]. However, DDD does not take
into account the weight and the age of the child. Therefore,
DDD is a questionable paediatric methodology and the DOT
is therefore preferable [21].
Currently, little is known about paediatric antibiotic use in
the Netherlands and official ASP in paediatrics have not been
introduced yet. Compared to other European countries, the
numbers of antimicrobial prescriptions are low, but the num-
ber of inappropriate prescriptions is still worrying and antibi-
otic resistance is rising steadily [13]. Patterns of antibiotic
prescription for specific diseases differ from country to coun-
try but also from one hospital to another [21]. Awareness of
antibiotic prescription patterns could aid in identifying areas
of inappropriate antibiotic prescribing and could contribute to
a better antibiotic prescription policy. The aim of this study is
to analyse qualitative and quantitative trends in time with re-
spect to total and disease-specific antimicrobial agent use in a
secondary paediatric care setting.
Materials and methods
Setting and ethics
This study was performed in the paediatric and neonatal ward
of a secondary care urban teaching hospital in Rotterdam, the
Netherlands (Franciscus Gasthuis, 21 paediatric beds; 18 neo-
natology beds including post-intensive care/high care). About
55% of the admissions on the neonatology wards are neonates
born < 37 weeks of gestational age, but all are > 30 weeks of
postmenstrual age. The most common infectious syndromes
on the paediatric ward that require antibiotics are fever of
unknown origin, lower respiratory tract infection, and urinary
tract infection. In this hospital; since 2014, two consultant
paediatricians regularly discuss antibiotic management and
local guidelines with both the senior and junior doctors prior
and after initiation of antimicrobial therapy. Moreover, in
2014, new protocols on lower respiratory and urinary tract
infection were introduced. Two specific topics were studied:
the total inpatient antibiotic use per year (2010 to 2015) and
antibiotic prescriptions for two important infectious discharge
diagnoses on the paediatric ward, namely lower respiratory
tract infection (LRTI) and urinary tract infection (UTI) (2008
and 2015). The local ethics review board deemed formal eth-
ical approval of the study unnecessary because of the absence
of risk for patients. The data were stored anonymously.
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Data collection
Admission data for the paediatric and neonatology wards were
obtained from the hospital database. Admission data from be-
fore 2010 could unfortunately not be reliably obtained. Single
day admissions for diagnostic tests, chemotherapy courses, or
blood transfusions were excluded. Children admitted for a non-
paediatric speciality (e.g. surgery or ENT) were excluded be-
cause the paediatricians were not the primary responsible doc-
tors. Since 2008, the pharmacy has stored all prescription data
electronically. All prescriptions with the Anatomical
Therapeutic Chemical classification-code (ATC) J01 for anti-
bacterials were extracted from its computer system.
For the first part of the study, both databases were matched
and the patient medical file was manually checked in case of
differences in admission and antibiotic therapy duration. All
files of children on co-trimoxazole (TMP/SMX) and trimeth-
oprim therapy were checked manually; prophylactic prescrip-
tions were excluded. Paediatric oncology patients (mainly leu-
kaemia) were excluded from the analyses because in 2013,
oncology treatment was discontinued in this hospital because
of local policies. For the second part of the study, the pharma-
cy database was used to identify the children who were pre-
scribed antibiotics for a LRTI or UTI in both 2008 (the first
year data available) and 2015. Data were then retrieved from
the medical files of these children.
Variables
For the estimation of the total inpatient antibiotic use, vari-
ables were obtained per year and included age at admission,
total number of admission days per year, days of antibiotic
therapy (DOT; total, per ATC group, intravenous, and oral).
The DOT per patient was calculated as the sum of antibiotics
used per patient per day. Antibiotic consumption for the spe-
cific wards was expressed as DOT per 100 (in) patient-days
(DOT/100PD) and estimated separately for every year. For the
second part of the study, the following variables were noted:
patient age, diagnostic parameters (C-reactive protein, white
blood cell count, chest X-rays, cultures), comorbidity, admis-
sion duration, antibiotic prescriptions (including route of ad-
ministration, dose, length of therapy, empirical and targeted/
narrowed use). The total antibiotic prescription was studied,
including discharge medication.
Data analysis
Data were stored in an online research database (Castor EDC).
Statistical analysis was performed with SPSS 23 (IBM SPSS
Statistics).
Demographical data were analysed by descriptive statistics,
including median and mean values with interquartile range or
standard deviation for numerical data and proportions for
categorical data. The Shapiro-Wilk test was used to test for
normality of the distribution. Trends in DOT/100PD (total, per
ATC group, oral, intravenous) for the period of 2010–2015
were analysed by time series analysis (ARIMA) for non-
independent data. The data of the 2008/2015 patient cohorts
were compared by using the Mann-Whitney U test, the chi-
square, or Fisher’s exact test. p values < 0.05 were considered
statistically significant.
Results
Trends in days of antibiotic therapy
The number of admissions and total admission duration per
year are shown in Table 1. Additionally, details with respect to
diagnoses are shown to compare case mix and severity during
the years. There were no significant trends in patient case mix
and severity; the admission duration seemed lower in 2015
compared to the other years and can be partly explained by
the small percentage of early pre-terms (< 32 weeks of gesta-
tional age) admitted in 2015.
Neonatology ward
The total DOT/100PD varied over the years from 22.9 to 34.4
(Fig. 1a). The most commonly prescribed antibiotics were
beta-lactams, namely penicillins (J01C) and cephalosporins
(J01D). The total DOT/100PD did not change in time (R2 =
0.17, p = 0.42). The combined penicillin and cephalosporin
DOT/100PD increased from 20 to 32 but no significant dif-
ferences in the DOT/100PDwere calculated because of strong
fluctuations. Antibiotics were mainly given intravenously
(Fig. 1a, supplementary materials). No significant differences
were seen in the route of administration of antibiotics over the
years (intravenous R2 = 0.40, p = 0.18).
The post-delivery infants with risk factors for complica-
tions were observed in the maternity ward for several hours
or even days, depending on the condition. The proportion of
these infants who were prescribed antibiotics for suspected
early-onset sepsis ranged from 2.1 to 7.5% per year; no trend
in time was observed. For the majority of these infants (65.2–
80.5%), antibiotic therapy was discontinued within 48 h be-
cause of negative blood culture, re-assuring clinical condition
and inflammatory parameters.
Paediatric ward
The total DOT/100PD varied over the years from 28.6 to 44.9
(Fig. 1b). No trend in time was observed (R2 = 2.7E−6, p =
0.99), although 2015 seems to show a decrease in DOT/
100PD compared to the previous years. The beta-lactam pen-
icillins (J01C) and cephalosporins (J01D) represent 73–84%
Eur J Pediatr
of the total yearly DOT.Most frequently prescribed penicillins
were amoxicillin and amoxicillin/clavulanic acid; no signifi-
cant differences in the DOTwere seen in this group of antibi-
otics over the years (R2 = 0.22, p = 0.36). Most frequently
prescribed cephalosporins were cefotaxime and ceftriaxone.
Cephalosporin prescriptions showed a significant decrease
(DOT/100PD 11.61 in 2011 vs. 5.10 in 2015; R2 = 0.97, p <
0.001). The macrolide/lincosamide (J01F) group is the third
Table 1 Admission data
2010 2011 2012 2013 2014 2015
Total admissions neonatology 382 423 460 390 392 410
Mean admission duration neonatology (days) 14.9 14.0 14.8 16.4 16.0 11.6
Total admission duration (days) neonatology 5675 5909 6783 6394 6220 4756
Percentage gestational age < 32 weeks 9.9 11.8 11.1 13.8 18.3 8.0
Total admissions paediatrics 1155 1218 1319 1256 1444 1465
Mean admission duration paediatrics (days) 4.5 3.9 3.8 3.4 3.4 3.2
Total admission duration (days) paediatrics 5209 4729 4897 4407 4636 4353
Percentage infectious diseases paediatrics
Total 29.9 24.3 28.5 28.9 26.1 23.2
LRTI 9.1 8.8 9.8 9.4 8.6 8.4
a
b
Fig. 1 a Total DOT/100PD
neonatology ward. DOT R2 =
0.17 (p = 0.42). ATC groups are
shown in different shades. b Total
DOT/100PD paediatric ward.
Total DOT R2 = 2.7E−6 (p =
0.99). ATC groups are shown in
different shades
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most often prescribed group of antibiotics. No decrease was
observed for this group (R2 = 0.32, p = 0.24).
The intravenous DOT/100PD varied from 9.9 to 20.5 and
the oral DOT/100PD varied from 13.0 to 26.8 per year
(Fig. 1b, supplementary materials). A trend was observedwith
respect to fewer intravenous DOT/100PD over the years
(R2 = 0.63, p = 0.06).
Top 3 inpatient antibiotic prescriptions per year
For every year, the top 3 of most often prescribed antibiotics
on the paediatric ward was established. In 2010, ceftriaxone
had a number 1 position, but through the years, ceftriaxone
was replaced by amoxicillin and amoxicillin/clavulanic acid
(place 1 and 2 respectively).
Trends in total antibiotic prescriptions for urinary
tract infections and respiratory tract infections
All patients admitted in 2008 and 2015 with a UTI or a LRTI
were reviewed. The latter group consisted of patients with the
discharge codes of pneumonia or bronchiolitis.
Urinary tract infection
The baseline and microbiological characteristics of the patients
included for urinary tract infection are shown in supplementary
Table 1. Only gender was significantly different between the
years. E. coli resistance for penicillins, cephalosporins, and
TMP/SMX occurred more often in 2010 compared to 2015.
In Table 2, a comparison of the duration of antibiotic ther-
apy between 2008 and 2015 is shown. The median total length
of stay was 3 days in both years and the median total duration
of treatment was 10 days in both years. The median total
duration of intravenous therapy significantly decreased from
3 days in 2008 to 2 days in 2015 (p = 0.02).
The empiric antibiotic therapy for both years is shown in
Fig. 2. In 2008, cephalosporin antibiotics (93%) were the most
commonly prescribed empirical antibiotics. In 2015, the num-
ber of empiric cephalosporin prescriptions was significantly
lower (93 vs. 45%, p = 0.002) and replaced by penicillin anti-
biotics (amoxicillin/clavulanic acid). De-escalation and oral
switch therapy were performed in 87 and 88% of patients in
2008, for 100% of patients in 2015 when deemed appropriate.
Lower respiratory tract infection
The demographic and clinical characteristics of the patients
included for LRTI are shown in supplementary Table 2.
When the patients were admitted, they were all having low
oxygen saturation (≤ 92% in room air) and/or apneas. In 2008,
262 patients were admitted for LRTI. Of these patients, 73
(27.8%) received antibiotic treatment. In 2015, 334 patients
were admitted for LRTI. In total, 97 patients (29.0%) received
antibiotic treatment.
The 2008 cohort had higher median inflammatory param-
eters; however, the number of patients tested was significantly
Table 2 Characteristics of
antibiotic therapy in patients with
urinary tract infection
Characteristics Year N Median (IQR) Mean (SD) p value*
Length of stay (days) 2008
2015
27
11
3.0 (3.0–5.0)
3.0 (2.0–5.0)
3.7 (1.6)
3.1 (1.9)
0.16
Total duration of treatment (days) 2008
2015
27
11
10.0 (6.0–10.0
10.0 (10.0–10.0)
8.0 (3.2)
9.7 (0.9)
0.22
Total duration of intravenous treatment (days) 2008
2015
27
11
3.0 (2.0–4.0)
2.0 (0.0–3.0)
3.1 (1.5)
1.8 (1.7)
0.02
Total duration of empirical treatment (days)# 2008
2015
27
11
3.0 (3.0–4.0)
3.0 (2.0–3.0)
3.7 (2.3)
2.7 (1.3)
0.23
*Mann-Whitney U test
# Duration until change of treatment according to culture results
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Fig. 2 Empiric antibiotic therapy for urinary tract infection in 2008 and
2015. Cephalosporin prescriptions decrease significantly (chi-square, p <
0.01)
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lower in 2015. The number of additional investigations (blood
cultures, chest X-rays, C-reactive protein, and white blood cell
count) for LRTI decreased significantly over the years.
Despite the decrease in additional investigations for LRTI,
no difference was seen in the percentage of patients that
started on antibiotics for LRTI.
In Table 3, characteristics of empiric antibiotic therapy are
shown. The median length of stay in the hospital was for
3 days for both years. The total treatment duration decreased
significantly (p < 0.001). A significant decrease was also no-
ticed in total duration of intravenous treatment (p < 0.001).
Intravenous-to-oral switch was performed for 96% of patients
in 2008 and 100% in 2015when deemed appropriate. In 2015,
the majority of patients initiated with oral antibiotics (91.8 vs.
64.4% in 2008).
Figure 3 illustrates the empirical antibiotics for lower respi-
ratory tract infection. For both years, penicillin antibiotics
were the most commonly prescribed antibiotics (respectively
55 and 66%). The differences in penicillin, macrolide, and
cephalosporin prescriptions were not significant (p = 0.18).
However, the penicillin prescriptions were significantly more
often smaller in spectrum in 2015 (51% amoxicillin and 49%
amoxicillin/clavulanic acid in 2008 vs. 72% amoxicillin and
28% amoxicillin/clavulanic acid in 2015 (p = 0.02)).
Discussion
This study is the first that focused on the trend of antibiotic
prescriptions in time in a secondary paediatric care setting in
Northern Europe. Although no significant trend in total DOT/
100PD could be observed on the paediatric and neonatology
ward, trends regarding specific antibiotic classes, route, and
duration were observed. This setting differs from a tertiary
setting because of the absence of haemato-oncology and in-
tensive care patients: a population with a high antibiotic con-
sumption. However, since antibiotics are frequently pre-
scribed in all fields of paediatrics, it is important to investigate
all possibilities for reducing antibiotic use in the light of anti-
microbial stewardship.
The average DOT/100PD for the paediatric ward in our
study was between 35 and 45. Recent data from smaller and
larger American community hospitals showed the median
DOT/100PD over 2011–2013 for paediatric wards including
surgery to be 49, somewhat higher compared to our figures
[23]. Ideally, figures should be compared with secondary pae-
diatric wards from an identical setting enabling doctors to
identify differences in and rationales for their prescription be-
haviour. Other studies reporting a comparable setting are not
yet available. A Canadian children’s hospital study showed
DOT/100PD to reduce from ~94 to 76 in about the same time
period (2011–2013) [3]. Average DOT/100PD in American
freestanding children’ hospitals ranged from ~77 in 2004 to
~65 in 2012 [10]. Another American study analysing data
from university hospitals from 2002 to 2007 showed DOT/
100PD to be 54–56; no trend in time was observed, but this
study was performed before the formal ASP were initiated
[20]. In our study, the secondary care setting and the restricted
antibiotic use in the Netherlands in general might be the main
factors explaining the lower use of antimicrobial agents and
the absence of a trend in total DOT/100PD compared to the
Table 3 Factors related to
antibiotic therapy in patients with
lower respiratory tract infection
Characteristics (unit) Year N Median (IQR) Mean (SD) p value*
Length of stay (days) 2008
2015
73
97
3.0 (2.0–6.0)
3.0 (2.0–5.5)
4.5 (3.3)
4.3 (3.3)
0.69
Total duration of treatment (days) 2008
2015
73
97
7.0 (7.0–12.0)
7.0 (5.0–7.0)
9.2 (3.3)
6.6 (2.3)
< 0.01
Total duration of intravenous treatment (days) 2008
2015
73
97
0.0 (0.0–2.5)
0.0 (0.0–0.0)
1.4 (2.1)
0.3 (1.0)
< 0.01
Total duration of empirical treatment (days) 2008
2015
73
97
7.0 (7.0–12.0)
7.0 (5.0–7.0)
9.2 (3.3)
6.5 (2.3)
< 0.01
*Mann-Whitney U test
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Fig. 3 Empiric antibiotic therapy for lower respiratory tract infection
2008 and 2015. Cephalosporin prescriptions did not decrease
significantly (chi-square, p = 0.18); a difference in penicillin
prescriptions was observed (increase in amoxicillin and decrease in
amoxicillin/clavulanic acid prescriptions in 2015; p = 0.02)
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other American studies, including the community hospital
study. A recent study reported the outcome of an ASP at ter-
tiary general paediatric wards (excluding surgery) in
Germany, calculating a DOT/100 PD of 48 before interven-
tion and 43 after intervention [14]. This setting can probably
be best compared to a secondary care setting. The ARPEC
studies showed point prevalence (PP) of antibiotic use in gen-
eral medical paediatric and neonatal wards of 39 and 12.3%,
respectively. These are merged data from different hospitals
worldwide (both tertiary and secondary); the UK data show a
PP for general secondary and tertiary wards of 36.4 and
37.5%. This metric can also not be fully compared because
of the different denominator. However, the point prevalence is
an easier metric since it can be calculated without the need for
hospital information technology services, but may not portray
the magnitude of antibiotic use over time [8, 24].
The year 2015 had a somewhat lower, although not statis-
tically significant, paediatric DOT/100PD compared to the
other years. Since 2014, antibiotic case rounds and teaching
have been installed in this hospital to make the staff and junior
doctors more aware of the possible consequences of antimi-
crobial treatment. During the case rounds, all infectious pa-
tients are reviewed and indications and choices for antimicro-
bial therapy are discussed. Additionally, antibiotic prescrip-
tions are discussed at the morning report. Whether this will
lead to a sustained trend or is the result of temporal changes in
case mix should be analysed in the future. The neonatology
department showed a strongly fluctuating DOT/100PD with a
non-significant increase from 24 to 34; this might be ex-
plained by case mix (e.g. higher patient turnover in 2015).
Third-generation cephalosporin consumption and the intra-
venous route for the paediatric ward were significantly lower
over the years; this was shown both in the global DOT study
and the supporting UTI/LRTI study.
Unfortunately, admission figures to calculate the patient
days from before 2010 could not be reliably obtained.
This study identified that the total duration of antibiotic ther-
apy in patients with LRTI significantly decreased. In addition,
intravenous antibiotic treatment decreased in both patients with
LRTI and UTI. A recent review emphasised the importance of
switching to oral agents as soon as clinical improvement has
occurred [15]. The observed reductions in antibiotic use in these
groups could be attributable to increased awareness of antimicro-
bial resistance and a selection of interventions in the context of
antimicrobial stewardship. Regular feedback and new protocol
development aided in the reduced use of broad-spectrum cepha-
losporins and penicillins. In 2014, a new local UTI protocol was
implemented with emphasis on an early iv-oral switch and em-
pirical treatment with intravenous or oral amoxicillin/clavulanic
acid in the absence of risk factors such as prior culture results
with resistant pathogens. The amoxicillin/clavulanic acid resis-
tance in paediatric E. coli isolates was still low (< 20%) in this
hospital, but might change in the future. Additionally, a national
childhood community-acquired pneumonia (CAP) protocol was
published, emphasising the limited value of additional investiga-
tions and the shorter duration of antibiotics (5 days) needed for
non-complicated LRTI. In our setting, regular feedback and local
and national protocols have definitely created awareness
amongst doctors regarding the preferred spectrum, route, and
duration of antibiotics for LRTI. Moreover, significantly less
diagnostic tests were requested. In other studies, identical results
were observed [18, 22]. After implementing stewardship prac-
tices, cephalosporin and amoxicillin/clavulanic acid use for CAP
could be restricted and replaced by amoxicillin.
Strikingly, the percentage of patients who were adminis-
tered any antibiotic for LRTI did not decrease in our study, but
the number of additional investigations for LRTI decreased
significantly. Education about the aetiology of LRTI in infants
could possibly further reduce the percentage of infants receiv-
ing antibiotics for a LRTI, which are mostly viral in nature.
The strength and originality of this study is that it focuses on
both total and detailed aspects of antibiotic prescriptions. Apart
from analysing inpatient antibiotic use by DOT, this study also
evaluated the in- and outpatient antibiotic use for one infectious
disease episode, which together reflect the full antibiotic pre-
scription. Both analyses showed a decrease in third-generation
cephalosporin use over the years. Although the specific dis-
eases sub study only compared 2 years, the outcomes are sup-
ported by the DOTstudy and the interventions in the context of
ASP. This study was restricted to one centre; consequently,
implementations and outcomes might not be extrapolated to
other clinical centres. Ideally DOT’s should be calculated
(semi)-automatically by hospital software programs. This al-
lows for comparing DOT’s easily between time periods and
hospitals. However, using DOT’s in paediatrics also has some
limitations. DOT’s include the assumption that antibiotic dos-
ing is appropriate, and the quality of the prescriptions cannot be
assessed, e.g. broad-spectrum monotherapy leading to fewer
DOT’s compared to narrow-spectrum combination therapy.
Future research should be aimed towards evaluating compara-
ble care units with comparable resistance rates and understanding
differences in antibiotic prescribing and barriers to rational pre-
scribing. This will aid in developing national antimicrobial stew-
ardship priorities and allow for more selective antimicrobial use.
Concluding, in this secondary setting, a significant decrease
in overall inpatient cephalosporin use and cephalosporin use for
UTI and LRTI was identified. No trend in total DOT/100PD
could be observed for both the neonatal and paediatric wards.
However, the total intravenous administration was shortened in
time. The total treatment duration and proportion of broad-
spectrum beta-lactam antibiotics significantly decreased for
LRTI. Increased awareness of antimicrobial resistance and a
selection of interventions in the context of antimicrobial stew-
ardship could explain this decrease in antibiotic use. This de-
crease in antibiotic use is feasible and important in non-tertiary
paediatric wards and outpatient clinics.
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